These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3011760)

  • 21. [Successful electroconvulsive therapy in a pregnant woman with neuroleptic malignant syndrome].
    Verwiel JM; Verwey B; Heinis C; Thies JE; Bosch FH
    Ned Tijdschr Geneeskd; 1994 Jan; 138(4):196-9. PubMed ID: 8107921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM; Shifrar KA
    Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple ECT late in the course of neuroleptic malignant syndrome.
    McKinney P; Kellner C
    Convuls Ther; 1997 Dec; 13(4):269-73. PubMed ID: 9437570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
    Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low melanin content of substantia nigra in a case of neuroleptic malignant syndrome.
    Gertz HJ; Schmidt LG
    Pharmacopsychiatry; 1991 May; 24(3):93-5. PubMed ID: 1891487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical neuroleptic malignant syndrome with long-term clozapine.
    Corallo CE; Ernest D
    Crit Care Resusc; 2007 Dec; 9(4):338-40. PubMed ID: 18052897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case report of death from neuroleptic malignant syndrome].
    Gotouda H; Nagao M; Mizukami K; Takatori T
    Nihon Hoigaku Zasshi; 1988 Feb; 42(1):90-3. PubMed ID: 3411805
    [No Abstract]   [Full Text] [Related]  

  • 29. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine.
    Siever LJ; Uhde TW
    Biol Psychiatry; 1984 Feb; 19(2):131-56. PubMed ID: 6324896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trimipramine-induced neuroleptic malignant syndrome after transient psychogenic polydipsia in one patient.
    Langlow JR; Alarcon RD
    J Clin Psychiatry; 1989 Apr; 50(4):144-5. PubMed ID: 2925603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AANA journal course. Update for nurse anesthetists. Neuroleptic malignant syndrome.
    Waldorf S
    AANA J; 2003 Oct; 71(5):389-94. PubMed ID: 14625976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of impending neuroleptic malignant syndrome associated with Shy-Drager syndrome].
    Kumagai R; Harada T; Kurokawa K; Okazaki M; Egi N; Shimote K; Nakamura S
    No To Shinkei; 1998 Aug; 50(8):745-9. PubMed ID: 9757468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome in the intensive care unit.
    Sing RF; Branas CC; Marino PL
    J Am Osteopath Assoc; 1993 May; 93(5):615-8. PubMed ID: 8314724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lethal catatonia and neuroleptic malignant syndrome. A dopamine receptor shut-down hypothesis.
    Osman AA; Khurasani MH
    Br J Psychiatry; 1994 Oct; 165(4):548-50. PubMed ID: 7804674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Atypical" neuroleptic malignant syndrome and the spectrum of malignant cerebrotoxic syndromes.
    Choi-Kain LW; Pope HG
    Harv Rev Psychiatry; 2007; 15(4):181-6. PubMed ID: 17687712
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperthermic reaction to haloperidol with rigidity, associated to central core disease.
    Calore EE; Cavaliere MJ; Perez NM; Russo DH; Wakamatsu A; Razzouk D
    Acta Neurol (Napoli); 1994 Aug; 16(4):157-61. PubMed ID: 7856468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease.
    Mateo D; Muñoz-Blanco JL; Giménez-Roldán S
    Clin Neuropharmacol; 1992 Feb; 15(1):63-8. PubMed ID: 1533561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic malignant syndrome.
    Bristow MF; Kohen D
    Br J Hosp Med; 1996 Apr 17-30; 55(8):517-20. PubMed ID: 8732227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuroleptic malignant syndrome].
    Filaković P; Vuksić Z; Pozgain I
    Lijec Vjesn; 1991; 113(11-12):413-5. PubMed ID: 1669612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.